Illumina has named Tina Nova as the senior vice president and general manager of its oncology business. Nova replaces Rick Klausner, who has served as interim oncology leader since January. Klauner will continue to serve as senior vice president and chief medical officer, Illumina said.
Nova is the co-founder of Genoptix and previously served as the firm's president and CEO. She also co-founded Nanogen, where she was COO and president. Nova holds a BSc in biological sciences from the University of California, Irvine and a PhD in biochemistry from the University of California, Riverside.
Paul Menter has joined SomaLogic as vice president and general manager of its life science tools business.
Menter most recently served as general manager of Bioseparations at Thermo Fisher Scientific. Before that, he was division manager of lab separations and of North American sales and service at Bio-Rad Laboratories.